Matthias E. Egger
Elite in Kaposi Sarcoma

Matthias E. Egger

Zurich, ZH, CH 
Elite in Kaposi Sarcoma
Zurich, ZH, CH 
OverviewLocationsClinical Research

Overview

Matthias Egger practices in Zurich, Switzerland. Mr. Egger is rated as an Elite expert by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are HIV/AIDS, Kaposi Sarcoma, Aspergillosis, Adult Soft Tissue Sarcoma, and Hepatectomy.

His clinical research consists of co-authoring 567 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles in the study of Kaposi Sarcoma.

Gender
Male

Locations

Zurich, ZH, Switzerland
Other Locations
Bern, BE, Switzerland
Sankt Gallen, SG, Switzerland
Ullmannstrasse 13a, 9014 St, Gallen, 9014, Switzerland
Yverdon-les-bains, VD, Switzerland
Solothurn, SO, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A 24 Weeks Activity Program in Patients With Early Breast Cancer Receiving Aromatase Inhibitor Therapy. A Multicenter Randomized Phase III Trial
A 24 Weeks Activity Program in Patients With Early Breast Cancer Receiving Aromatase Inhibitor Therapy. A Multicenter Randomized Phase III Trial
Enrollment Status: Completed
Publish Date: June 27, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
An Open-label 2:1 Randomized Phase II Study of Panitumumab Plus FOLFOXIRI or FOLFOXIRI Alone as First-line Treatment of Patients With Non-resectable Metastatic Colorectal Cancer and RAS Wild Type
An Open-label 2:1 Randomized Phase II Study of Panitumumab Plus FOLFOXIRI or FOLFOXIRI Alone as First-line Treatment of Patients With Non-resectable Metastatic Colorectal Cancer and RAS Wild Type
Enrollment Status: Completed
Publish Date: June 15, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

567 Total Publications

Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET Statement.
Transparent Reporting of Observational Studies Emulating a Target Trial-The TARGET Statement.
Journal: JAMA
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Egger's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 53 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile